SC

Stempoint Capital Portfolio holdings

AUM $583M
1-Year Est. Return 185.08%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+185.08%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$583M
AUM Growth
+$86.8M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
112
New
Increased
Reduced
Closed

Top Buys

1
+$25.6M
2
+$24.6M
3
+$16.2M
4
CNTA
Centessa Pharmaceuticals
CNTA
+$12.6M
5
ADPT icon
Adaptive Biotechnologies
ADPT
+$9.9M

Top Sells

1
+$63.7M
2
+$22.2M
3
+$21.1M
4
QURE icon
uniQure
QURE
+$18.5M
5
WVE icon
Wave Life Sciences
WVE
+$15.4M

Sector Composition

1 Healthcare 100%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLPT icon
26
ClearPoint Neuro
CLPT
$354M
$6.59M 1.13%
481,858
+465,207
ARQT icon
27
Arcutis Biotherapeutics
ARQT
$3.04B
$6.53M 1.12%
224,740
-187,153
EYPT icon
28
EyePoint Inc
EYPT
$1.25B
$6.46M 1.11%
+353,849
IMTX icon
29
Immatics
IMTX
$1.5B
$6.41M 1.1%
+610,308
OCUL icon
30
Ocular Therapeutix
OCUL
$2.14B
$6.35M 1.09%
522,693
+163,223
RYTM icon
31
Rhythm Pharmaceuticals
RYTM
$6.06B
$6.31M 1.08%
58,915
-32,529
PRAX icon
32
Praxis Precision Medicines
PRAX
$9.54B
$6.21M 1.07%
+21,067
APGE icon
33
Apogee Therapeutics
APGE
$6.88B
$6.08M 1.04%
+80,574
INCY icon
34
Incyte
INCY
$19.5B
$6.07M 1.04%
61,435
+17,681
IDYA icon
35
IDEAYA Biosciences
IDYA
$2.98B
$5.59M 0.96%
161,659
-210,166
ASMB icon
36
Assembly Biosciences
ASMB
$464M
$5.33M 0.91%
156,728
+90,598
MAZE
37
Maze Therapeutics
MAZE
$1.4B
$5.22M 0.9%
+125,877
PTGX icon
38
Protagonist Therapeutics
PTGX
$6.76B
$5.19M 0.89%
59,430
+11,476
LLY icon
39
Eli Lilly
LLY
$828B
$5.11M 0.88%
+4,759
TRVI icon
40
Trevi Therapeutics
TRVI
$1.96B
$5M 0.86%
399,557
+48,847
RVMD icon
41
Revolution Medicines
RVMD
$29.5B
$4.94M 0.85%
62,032
-123,348
VRDN icon
42
Viridian Therapeutics
VRDN
$1.51B
$4.8M 0.82%
+154,320
ABUS icon
43
Arbutus Biopharma
ABUS
$930M
$4.75M 0.81%
986,751
+781,363
MLTX icon
44
MoonLake Immunotherapeutics
MLTX
$1.32B
$4.59M 0.79%
+348,401
CTMX icon
45
CytomX Therapeutics
CTMX
$1.04B
$4.41M 0.76%
+1,036,311
XFOR icon
46
X4 Pharmaceuticals
XFOR
$390M
$3.59M 0.62%
898,465
+343,054
WHWK
47
Whitehawk Therapeutics
WHWK
$194M
$3.53M 0.61%
1,458,807
+1,034,725
DNTH icon
48
Dianthus Therapeutics
DNTH
$5.08B
$3.27M 0.56%
79,284
+37,902
ASND icon
49
Ascendis Pharma
ASND
$15B
$3.16M 0.54%
14,842
-307
RGEN icon
50
Repligen
RGEN
$7.4B
$2.57M 0.44%
+15,707
1
2
3 4 5